Clinical evaluation of CMA in the treatment of prostatic cancer
Forty five patients with previously untreated prostatic cancer were given chlormadinone acetate (CMA) at a dose of 100 mg/day (mean 12.6 months), and 42 of them were evaluated for effectiveness. Overall response evaluation revealed 19 complete responses (45.2%), 14 partial responses (33.3%), 4 minor...
| Publié dans: | Hinyokika kiyo. Acta urologica Japonica. - 1962. - 32(1986), 12 vom: 30. Dez., Seite 1821-30 |
|---|---|
| Auteur principal: | |
| Autres auteurs: | , , , , , , |
| Format: | Article |
| Langue: | Japanese |
| Publié: |
1986
|
| Accès à la collection: | Hinyokika kiyo. Acta urologica Japonica |
| Sujets: | English Abstract Journal Article Chlormadinone Acetate 0SY050L61N Testosterone 3XMK78S47O Luteinizing Hormone 9002-67-9 Follicle Stimulating Hormone 9002-68-0 plus... |